Asset
Lonvoguran
Intellia Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06634420 | phase3 | active_not_recruiting | 2025-01-15 | 2026-02-10 | Intellia Therapeutics | HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) |
FDA applications (0)
This company has no applications containing this asset.